BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16142787)

  • 1. Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones.
    Nicolin V; Ponti C; Narducci P; Grill V; Bortul R; Zweyer M; Vaccarezza M; Zauli G
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct; 286(2):945-54. PubMed ID: 16142787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression.
    Uchiyama S; Yamaguchi M
    J Cell Biochem; 2006 Aug; 98(5):1185-95. PubMed ID: 16514646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.
    Mozar A; Haren N; Chasseraud M; Louvet L; Mazière C; Wattel A; Mentaverri R; Morlière P; Kamel S; Brazier M; Mazière JC; Massy ZA
    J Cell Physiol; 2008 Apr; 215(1):47-54. PubMed ID: 17894387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
    Yamaguchi M; Uchiyama S
    Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
    Yaroslavskiy BB; Li Y; Ferguson DJ; Kalla SE; Oakley JI; Blair HC
    J Cell Biochem; 2004 Apr; 91(5):962-72. PubMed ID: 15034931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1.
    Wattel A; Kamel S; Prouillet C; Petit JP; Lorget F; Offord E; Brazier M
    J Cell Biochem; 2004 May; 92(2):285-95. PubMed ID: 15108355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
    Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
    Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling-related gene expression in osteoclastic cells.
    Uchiyama S; Yamaguchi M
    J Cell Biochem; 2007 Jun; 101(3):529-42. PubMed ID: 17295206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin.
    Mancini L; Moradi-Bidhendi N; Brandi ML; Perretti M; MacIntyre I
    Biochem Biophys Res Commun; 2000 Dec; 279(2):391-7. PubMed ID: 11118297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis.
    Lee SK; Kalinowski JF; Jastrzebski SL; Puddington L; Lorenzo JA
    Endocrinology; 2003 Aug; 144(8):3524-31. PubMed ID: 12865334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis.
    Fox SW; Chambers TJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):868-72. PubMed ID: 11027561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 4 increases type 5 acid phosphatase mRNA expression in murine bone marrow macrophages.
    Lacey DL; Erdmann JM; Tan HL
    J Cell Biochem; 1994 Mar; 54(3):365-71. PubMed ID: 8200916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.
    Herrera BS; Bastos AS; Coimbra LS; Teixeira SA; Rossa C; Van Dyke TE; Muscara MN; Spolidorio LC
    J Periodontol; 2014 Apr; 85(4):e72-81. PubMed ID: 24059638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.